SCHEMBL2885071

SCHEMBL2885071

CCCSc1c[c]ccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
AR P10275 2/20 0.36
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
PKM P14618 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SOAT1 P35610 1/20 0.32
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3015784 0.89 MAOA (0.40) ALDH1A1MAPK1MAOAMAOBAR
SCHEMBL7276198 0.87 SOAT1 (0.36) ALDH1A1MAPK1MAOAMAOBAR
SCHEMBL11221141 0.85 THRA (0.38) MAOAMAOBSOAT1PTGS2
SCHEMBL11232325 0.85 THRA (0.38) MAOAMAOBSOAT1PTGS2
SCHEMBL972188 0.83
SCHEMBL5463978 0.80 ALDH1A1 (0.38) ALDH1A1MAPK1
SCHEMBL10534853 0.79 HTR7 (0.42) DRD2
SCHEMBL8508068 0.76 ALDH1A1 (0.34) ALDH1A1MAPK1
SCHEMBL3612916 0.75
SCHEMBL3017420 0.74 MAOA (0.41) MAOAMAOBRAB9AMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195289-B1 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF ANS INTERMEDIATES THERETO UNIV ROMA (IT) 2013-06-19 EP claimed
US-8304410-B2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto Università degli Studi di Roma “La Sapienza” (IT) 2012-11-06 US claimed
US-20100197672-A1 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF AND INTERMEDIATES THERETO UNIVERSITA DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) 2010-08-05 US claimed
EP-2195289-A2 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF ANS INTERMEDIATES THERETO Universita'Degli Studi di Roma "La Sapienza" (IT) 2010-06-16 EP claimed
EP-2045237-A1 Pyrrole compounds as inhibitors of mycrobacteria, synthesis thereof and intermediates thereto Universita'Degli Studi di Roma "La Sapienza" (IT) 2009-04-08 EP claimed
WO-2009040755-A2 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF ANS INTERMEDIATES THERETO Università degli Studi di Roma 'La Sapienza' (IT) 2009-04-02 WO claimed
US-7402589-B2 Tri-substituted ureas as cytokine inhibitors THE PROCTER & GAMBLE COMPANY (US) 2008-07-22 US claimed
EP-1737830-A1 TRI-SUBSTITUTED UREAS AS CYTOKINE INHIBITORS The Procter and Gamble Company (US) 2007-01-03 EP claimed
WO-2005105757-A1 TRI-SUBSTITUTED UREAS AS CYTOKINE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2005-11-10 WO claimed
US-20050245555-A1 Tri-substituted ureas as cytokine inhibitors THE PROCTER & GAMBLE COMPANY (US) 2005-11-03 US claimed
EP-2195289-B1 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF ANS INTERMEDIATES THERETO UNIV ROMA (IT) 2013-06-19 EP disclosed
US-8304410-B2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto Università degli Studi di Roma “La Sapienza” (IT) 2012-11-06 US disclosed
US-7803827-B2 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents; 1-(aminosulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(3,4-dimethylphenyl)-2-imidazolidinone WYETH LLC (US) 2010-09-28 US disclosed
US-20100197672-A1 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF AND INTERMEDIATES THERETO UNIVERSITA DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) 2010-08-05 US disclosed
EP-2195289-A2 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF ANS INTERMEDIATES THERETO Universita'Degli Studi di Roma "La Sapienza" (IT) 2010-06-16 EP disclosed
US-4673737-A ANTIBIOTICS/ HARVARD UNIVERSITY (US) 1987-06-16 US disclosed
EP-0211540-A1 Intermediates and process for antibiotics THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1987-02-25 EP disclosed
US-4147805-A VASODILATION, ANTISPASMODIC AGENTS, ANTICOAGULATNS, ADRENOLYTIC AGENTS MEAD JOHNSON & COMPANY (US) 1979-04-03 US disclosed
US-4120886-A APHIDICIDES PPG INDUSTRIES, INC. (US) 1978-10-17 US disclosed
US-4055656-A S-ARYL-N-CYCLOALKYLTHIOLCARBAMATES PPG INDUSTRIES, INC. (US) 1977-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245555-A1 Tri-substituted ureas as cytokine inhibitors IL1B, IL1A, IL6 ALDH1A1 455/4885MAPK1 1198/4885CA12 3132/4885
US-20100197672-A1 PYRROLE COMPOUNDS AS INHIBITORS OF MYCOBACTERIA, SYNTHESIS THEREOF AND INTERMEDIATES THERETO PPOX, FDPS, GGPS1 ALDH1A1 3225/4885MAPK1 409/4885CA12 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.